Aspects of gene polymorphisms in cerebral infarction: Inflammatory cytokines

Cellular and Molecular Life Sciences

Volumn 62, Issue 7-8, 2005, Pages 824-833

  Um, J Y ^a   Jeong, H J ^a   Park, R K ^b   Hong, S H ^c   Kim, H M ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Wonkwang University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Cerebral infarction; Gene polymorphisms; Inflammatory cytokines; Pathogenesis; Stroke

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA;

ATHEROSCLEROSIS; BRAIN INFARCTION; CYTOKINE RELEASE; CYTOLOGY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENETICS; HUMAN; PATHOGENICITY; PATHOLOGY; PROTEIN EXPRESSION; REVIEW; STROKE;

ANIMALS; CELL ADHESION MOLECULES; CEREBRAL INFARCTION; CYTOKINES; HUMANS; POLYMORPHISM, GENETIC;

EID: 18544382182     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4267-9     Document Type: Review

References (123)

1. Dirnagl U., Iadecola C. and Moskowitz M. A. (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci. 22: 391-397
2. Lee J. M., Zipfel G. J. and Choi D. W. (1999) The changing landscape of ischemic brain injury mechanisms. Nature 399: A7-A14
3. Stoll G., Jander S. and Schroeter M. (1998) Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56: 149-171
4. Emerich D. F., Dean R. L. 3rd and Bartus R. T. (2002) The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp. Neurol. 173: 168-181
5. Zaremba J. and Losy J. (2004) Cytokines in clinical and experimental ischemic stroke. Neurol. Neurochir. Pol. 38: S57-S62
6. Ross R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126
7. Woods A., Brull D. .J, Humphries S. E. and Montgomery H. E. (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur. Heart J. 21: 1574-1583
8. Alberts M. J. (2003) Stroke genetics update. Stroke 34: 342-344
9. Dinarello C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147
10. Stroemer R. P. and Rothwell N. J. (1998) Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat. J. Cereb. Blood Flow Metab. 18: 833-839
11. Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23: 618-625
12. Wang X., Yue T. L., Barone F. C., White R. F., Gagnon R. C. and Feuerstein G. Z. (1994) Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23: 103-114
13. Hillhouse E. W., Kida S. and Iannotti F. (1998) Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1beta in the cerebral cortex. Neurosci. Lett. 249: 177-179
14. Zhang Z., Chopp M., Goussev A. and Powers C. (1998) Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res. 784: 210-217
15. Loddick S. A. and Rothwell N. J. (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16: 932-940
16. Lawrence C. B., Allan S. M. and Rothwell N. J. (1998) Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10: 1188-1195
17. Allan S. M., Parker L. C., Collins B., Davies R., Luheshi G. N. and Rothwell N. J. (2000) Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. Proc. Natl. Acad Sci. USA 97: 5580-5585
18. Betz A. L., Yang G. Y. and Davidson B. L. (1995) Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15: 547-551
19. Garcia J. H., Liu K. F. and Relton J. K. (1995) Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147: 1477-1486
20. Lin M. T., Kao T. Y., Jin Y. T. and Chen C. F. (1995) Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res. Bull. 37: 595-598
21. Yang G. Y., Liu X. H., Kadoya C., Zhao Y. J., Mao Y., Davidson B. L. et al. (1998) Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cereb. Blood Flow Metab. 18: 840-847
22. Touzani O., Boutin H., Chuquet J. and Rothwell N. (1999) Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J. Neuroimmunol. 100: 203-215
23. McDowell T. L., Symons J. A., Ploski R., Forre O. and Duff G. W. (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38: 221-228
24. Di Giovine F. S., Takhsh E., Blakemore A. I. and Duff G. W. (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum. Mol. Genet. 1: 450
25. Bioque G., Crusius J. B., Koutroubakis I., Bouma G., Kostense P. J., Meuwissen S. G. et al. (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102: 379-383
26. Tarlow J. K., Blakemore A. I., Lennard A., Solari R., Hughes H. N., Steinkasserer A. et al. (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91: 403-404
27. Pociot F., Molvig J., Wogensen L., Worsaae H. and Nerup J. (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22: 396-402
28. Danis V. A., Millington M., Hyland V. J. and Grennan D. (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99: 303-310
29. Santtila S., Savinainen K. and Hurme M. (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 47: 195-198
30. Tountas N. A., Casini-Raggi V., Yang H., Di Giovine F. S., Vecchi M., Kam L. et al. (1999) Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 117: 806-813
31. Hurme M. and Santtila S. (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur. J. Immunol. 28: 2598-2602
32. Um J. Y., Moon K. S., Lee K. M., Yun J. M., Cho K. H., Moon B. S. et al. (2003) Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res. Mol. Brain Res. 115: 50-54
33. Um J. Y., Moon K. S., Lee K. M. and Kim H. M. (2003) Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine 23: 41-46
34. Du Y., Dodel R. C., Eastwood B. J., Bales K. R., Gao F., Lohmuller F. et al. (2000) Association of an interleukin 1α polymorphism with Alzheimer's disease. Neurology 55: 480-483
35. Grimaldi L. M. E., Casadei V. M., Ferri C., Veglia F., Licastro F., Annoni G. et al. (2000) Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann. Neurol. 47: 361-365
36. Nicoll J. A. R., Mrak R. E., Graham D., Stewart J., Cole G. M., Yang F. S. et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47: 365-368
37. Rebeck G. W. (2000) Confirmation of the genetic association of interleukin-1α with early onset sporadic Alzheimer's disease. Neurosci. Lett. 293: 75-77
38. Minster R. L., DeKosky S. T., Ganguli M., Belle S. and Kamboh M. I. (2000) Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann. Neurol. 48: 817-819
39. Ki C. S., Na D. L., Kim D. K., Kim H. J. and Kim J. W. (2001) Lack of association of the interleukin-1 alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann. Neurol. 49: 817-818
40. Kolsch H., Ptok U., Bagli M., Papassotiropoulos Schmitz A. S., Barkow K., Kockler M. et al. (2001) Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Ann. Neurol. 49: 818-819
41. Murphy G. M. Jr, Claassen J. D., DeVoss J. J., Pascoe N., Taylor J., Tinklenberg J. R. et al. (2001) Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele. Neurology 56: 1595-1597
42. Schulte T., Schols L., Muller T., Woitalla D., Berger K. and Kruger R. (2002) Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci. Lett. 326: 70-72
43. Luomala M., Lehtimaki T., Elovaara I., Wang X., Ukkonen M., Mattila K. et al. (2001) A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J. Neurol. Sci. 185: 123-127
44. Um J. Y. and Kim H. M. (2003) Frequencies of interleukin 1 gene polymorphisms in Koreans. Clin. Chem. 49: 2101-2102
45. Seripa D., Dobrina A., Margaglione M., Matera M. G., Gravina C., Vecile E. et al. (2003) Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc. Dis. 15: 276-281
46. Lee B. C., Ahn S. Y., Doo H. K., Yim S. V., Lee H. J., Jin S. Y. et al. (2004) Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci. Lett. 357: 33-36
47. Dziedzic T., Slowik A., Pera J. and Szczudlik A. (2004) Lack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 75: 170-171
48. Zee R. Y., Cook N. R., Cheng S., Reynolds R., Erlich H. A., Lindpaintner K. et al. (2004) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum. Mol. Genet. 13: 389-396
49. -1α. Immunogenetics 54: 82-86
50. Sciacca F. L., Ferri C., Vandenbroeck K., Veglia F., Gobbi C., Martinelli F. et al. (1999) Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology 52: 1896-1898
51. Wilkinson R. J., Patel P., Llewelyn M., Hirsch C. S., Pasvol G., Snounou G. et al. (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 189: 1863-1874
52. Clay F. E., Tarlow J. K., Cork M. J., Cox A., Nicklin M. J. and Duff G. W. (1996) Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum. Genet. 97: 723-726
53. Dewberry R., Holden H., Crossman D. and Francis S. (2000) Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20: 2394-2400
54. Ishihara Y., Nishihara T., Kuroyanagi T., Shirozu N., Yamagishi E., Ohguchi M. et al. (1997) Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J. Periodontal. Res. 32: 524-529
55. Tracey K. J. and Cerami A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9: 317-343
56. DeGraba T. J. (1997) Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 49: S515-S519
57. Maseri A. (1997) Inflammation, atherosclerosis and ischemic events - exploring the hidden side of the moon. N. Engl. J. Med. 336: 1014-1016
58. Selwyn A. P., Kinlay S. and Ganz P. (1997) Atherogenesis and ischemic heart disease. Am. J. Cardiol. 80: 3H-7H
59. Bazzoni F. and Beutler B. (1996) The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725
60. Barath P., Fishbein M. C., Cao J., Berensen J., Helfant R. H. and Forrester J. S. (1990) Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65: 297-302
61. Wilson A. G., Di Giovine F. S., Blakemore A. I. and Duff G. W. (1992) Single base polymorphism in the human tumour necrosis factor α (TNF α) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1: 353
62. Braun N., Michel U., Ernst B. P., Metzner R., Bitsch A., Weber F. et al. (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci. Lett. 215: 75-78
63. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O. and Duff G. W. (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195-3199
64. Wu W. S. and McClain K. L. (1997) DNA polymorphisms and mutation of the tumor necrosis-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J. Interferon Cytokine Res. 17: 631-635
65. McGuire W., Hill A. V., Allsopp C. E. M., Greenwood B. M. and Kwiatkowski D. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510
66. Collier P. M., Wojnarowska F., McGuire B. and Welsh K. I. (1994) Polymorphism of tumor necrosis factor a promoter region of the MHC is strongly associated with linear IgA disease and affects prognosis. Br. J. Dermatol. 131: 22
67. Wilson A. G., Clay F. E., Crane A. M., Cork M. J. and Duff G. W. (1995) Genetics of tumor necrosis factor alpha in dermatitis herpetiformis. J. Invest. Dermatol. 104: 856-858
68. Warzocha K., Ribeiro P., Bienvenu J., Roy P., Chariot C., Rigal D. et al. (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91: 3574-3581
69. Um J. Y. and Kim H. M. (2004) Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res. Mol. Brain Res. 122: 99-102
70. Um J. Y., An N. H. and Kim H. M. (2003) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J. Mol. Neurosci. 21: 167-171
71. Cvetkovic J. T., Wallberg-Jonsson S., Stegmayr B., Rantapaa-Dahlqvist S. and Lefvert A. K. (2002) Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta and IL-1Ra genes. J. Rheumatol. 29: 212-219
72. Shu K. H., Lee S. H., Cheng C. H., Wu M. J. and Lian J. D. (2000) Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int. 58: 783-789
73. Venters H. D., Dantzer R. and Kelley K. W. (2000) A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci. 23: 175-180
74. Bowie A. and O'Neill L. A. (2000) Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59: 13-23
75. Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46: 187-216
76. Messer G., Spengler U., Jung M. C., Honold G., Blomer K., Pape G. R. et al. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173: 209-219
77. Pociot F., Briant L., Jongeneel C. V., Molvig J., Worsaae H., Abbal M. et al. (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23: 224-231
78. Stuber F., Petersen M., Bokelmann F. and Schade U. (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24: 381-384
79. Heinrich P. C., Castell J. V. and Andus T. (1990) Interleukin-6 and the acute phase response. Biochem. J. 265: 621-636
80. Berti R., Williams A. J., Moffett J. R., Hale S. L., Velarde L. C., Elliott P. J. et al. (2002) Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J. Cereb. Blood Flow Metab. 22: 1068-1079
81. Vila N., Castillo J., Davalos A. and Chamorro A. (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325-2329
82. Castellanos M., Castillo J., Garcia M. M., Leira R., Serena J., Chamorro A. et al. (2002) Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 33: 982-987
83. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J. S., Humphries S. et al. (1998) The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102: 1369-1376
84. Terry C. F., Loukaci V. and Green F. R. (2000) Cooperative influence of genetic polymorphism on interleukin-6 transcriptional regulation. J. Biol. Chem. 275: 18138-18144
85. Revilla M., Obach V., Cervera A., Davalos A., Castillo J. and Chamorro A. (2002) A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci. Lett. 324: 29-32
86. Greisenegger S., Endler G., Haering D., Schillinger M., Lang W., Lalouschek W. et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb. Res. 2003 110: 181-186.
87. Flex A., Gaetani E., Papaleo P., Straface G., Proia A. S., Pecorini G. et al. (2004) Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35: 2270-2275
88. Pola R., Flex A., Gaetani E., Flore R., Serricchio M. and Pola P. (2003) Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34: 881-885
89. Wang X., Siren A. L., Liu Y., Yue T. L., Barone F. C. and Feuerstein G. Z. (1994) Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res. Mol. Brain Res. 26: 61-68
90. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T. et al. (1994) Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656: 344-352
91. Okada Y., Copeland B. R., Mori E., Tung M. M., Thomas W. S. and del Zoppo G. J. (1994) P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25: 202-211
92. Bitsch A., Klene W., Murtada L., Prange H. and Rieckmann P. (1998) A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 29: 2129-2135
93. Clark W. M., Coull B. M., Briley D. P., Mainolfi E. and Rothlein R. (1993) Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J. Neuroimmunol. 44: 123-125
94. Fassbender K., Mossner R., Motsch L., Kischka U., Grau A. and Hennerici M. (1995) Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 26: 1361-1364
95. Di Napoli M., Papa F. and Bocola V. (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32: 917-924
96. Nathan C. F., Prendergast T. J., Wiebe M. E., Stanley E. R., Platzer E., Remold H. G. et al. (1984) Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J. Exp. Med. 160: 600-605
97. Baadsgaard O., Fisher G. J., Voorhees J. J. and Cooper K. D. (1990) Interactions of epidermal cells and T cells in inflammatory skin diseases. J. Am. Acad. Dermatol. 23: 1312-1316
98. Wiessner C., Gehrmann J., Lindholm D., Topper R., Kreutzberg G. W. and Hossmann K. A. (1993) Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. Acta Neuropathologica 86: 439-446
99. Peleman R., Wu J., Fargeas C. and Delespesse G. (1989) Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J. Exp. Med. 170: 1751-1756
100. Vercelli D., Jabara H. H., Lauener R. P. and Geha R. S. (1990) IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J. Immunol. 144: 570-573
101. Jelinek D. F. and Lipsky P. E. (1987) Regulation of human B lymphocyte activation, proliferation and differentiation. Adv. Immunol. 40: 1-59
102. Kuziel W. A. and Greene W. C. (1991) Interleukin-2. In: The Cytokine Handbook, pp. 83-102, Thomsen A. (ed.), Academic Press, London
103. Minami Y, Kono T, Yamada K. and Taniguchi T. (1992) The interleukin-2 receptors: insights into a complex signalling mechanism. Biochim. Biophys. Acta 1114: 163-177
104. Paul W. E. (1991) Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859-1870
105. Mitchell L. C., Davis L. S. and Lipsky P. E. (1989) Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142: 1548-1557
106. Te Velde A. A., Huijbens R. J., Heije K., de Vries J. E. and Figdor C. G. (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha and IL-6 by human monocytes. Blood 76: 1392-1397
107. Howells G., Pham P., Taylor D., Foxwel B. and Feldmann M. (1991) Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma. Eur. J. Immunol. 21: 97-101
108. Sempowski G. D., Beckmann M. P., Derdak S. and Phipps R. P. (1994) Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J. Immunol. 152: 3606-3614
109. Gauldie J., Richards C., Harnish D., Lansdorp P. and Baumann H. (1987) Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84: 7251-7255
110. Maimone D., Gregory S., Arnason B. G. and Reder A. T. (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32: 67-74
111. Frangogiannis N. G., Smith C. W. and Entman M. L. (2002) The inflammatory response in myocardial infarction. Cardiovasc. Res. 53: 31-47
112. Barone F. C., Arvin B., White R. F., Miller A., Webb C. L., Willette R. N. et al. (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28: 1233-1244
113. Jeong H. J., Seo S. Y., Noh H. S., Park H. S., Lee J. D., Kim K. S. et al. (2003) Regulation of TH1/TH2 cytokine production by Chungsim-Yeunja-Tang in patients cerebral infarction. Immunopharmacol. Immunotoxicol. 25: 29-39
114. Jeong H. J., Hong S. H., Park H. J., Kweon D. Y., Lee S. W., Lee J. D. et al. (2002) Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome focal stroke patients. Vascul. Pharmacol. 39: 63-68
115. Shin H. Y., Jeong H. J., Lee J. H., Joo J. C., Kim K. Y., Song H. J. et al. (2000) Regulatory effect of cytokine production in patients with cerebral infarction by Yulda-Hanso-Tang. Immunopharmacol. Immunotoxicol. 22: 183-193
116. Kim H. M., Shin H. Y., Jeong H. J., An H. J., Kim N. S., Chae H. J. et al. (2000) Reduced IL-2 but elevated IL-4, IL-6 and IgE serum levels in patients with cerebral infarction during the acute stage. J. Mol. Neurosci. 14: 191-196
117. Jeong H. J., Kang S. Y., Kim S. Y., Lee S. G., Lee S. G., Sung K. K. et al. (2003) The effect of Jeo-Dang-Tang on cytokines production in the patients with cerebral infarction. Immunopharmacol. Immunotoxicol. 25: 503-512
118. Jeong H. J., Chung H. S., Kim Y. H., Moon B. S., Sung K. K., Bai S. J. et al. (2004) Differential regulation by Seogak Jihwang-Tang on cytokines production in peripheral blood mononuclear cells from the cerebral infarction patients presenting with altered consciousness. J. Ethnopharmacol. 94: 289-294
119. Gazzinelli R. T., Oswald I. P., James S. L. and Sher A. (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148: 1792-1796
120. Perini F., Morra M., Alecci M., Galloni E., Marchi M. and Toso V. (2001) Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol. Sci. 22: 289-290
121. Spera P. A., Ellison J. A., Feuerstein G. Z. and Barone F. C. (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251: 189-192
122. Lane D. A. and Grant P. J. (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95: 1517-1532
123. Samani N. J. (1998) Molecular genetics of coronary artery disease: measuring the phenotype. Clin. Sci. 95: 645-646